Qube Research & Technologies (QRT)
GH icon

Qube Research & Technologies (QRT)’s Guardant Health GH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-67,116
Closed -$6.86M – 3748
2025
Q4 		$6.86M Sell
67,116
-502,979
-88% -$45M 0.01% 1579
2025
Q3 		$35.6M Buy
570,095
+315,896
+124% +$17.2M 0.04% 619
2025
Q2 		$13.2M Sell
254,199
-65,230
-20% -$2.91M 0.01% 1128
2025
Q1 		$13.6M Sell
319,429
-78,958
-20% -$3.41M 0.02% 947
2024
Q4 		$12.2M Buy
398,387
+338,257
+563% +$9.52M 0.02% 980
2024
Q3 		$1.38M Buy
+60,130
New +$1.7M ﹤0.01% 1911
2024
Q2 		– Sell
-128,430
Closed -$2.65M – 4138
2024
Q1 		$2.65M Buy
128,430
+79,536
+163% +$1.7M ﹤0.01% 1596
2023
Q4 		$1.32M Buy
+48,894
New +$1.28M ﹤0.01% 1759
2023
Q2 		– Sell
-658,700
Closed -$15.4M – 2612
2023
Q1 		$15.4M Buy
658,700
+284,516
+76% +$8.13M 0.07% 320
2022
Q4 		$10.2M Buy
374,184
+342,494
+1,081% +$15.7M 0.05% 484
2022
Q3 		$1.71M Buy
31,690
+7,999
+34% +$411K 0.01% 997
2022
Q2 		$956K Buy
+23,691
New +$1.17M 0.01% 1121
2021
Q3 		– Sell
-13,989
Closed -$1.74M – 2406
2021
Q2 		$1.74M Buy
+13,989
New +$1.88M 0.02% 752
2021
Q1 		– Sell
-48,475
Closed -$6.25M – 2103
2020
Q4 		$6.25M Buy
+48,475
New +$5.58M 0.09% 257

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GH Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Guardant Health (GH) in Q1 2026, closing a stake of 67,116 shares — an estimated $6.86M sold.

Qube Research & Technologies (QRT) first reported a position in GH in Q4 2020 and held it in 14 quarters. The position peaked at $35.6M in Q3 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 67,116 Guardant Health shares in Q1 2026, an estimated $6.86M.
  • Qube Research & Technologies (QRT) first reported a position in Guardant Health in Q4 2020 and held it in 14 quarters.
  • Qube Research & Technologies (QRT)'s Guardant Health position peaked at $35.6M in Q3 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.